It very much seems like bad news. I pose myself the following questions:
1) They only got made aware, one would think of there was a lack of evidence or material behind the inclusions that this would have been telegraphed
2) was this telegraphed by Novartis and as a result the company has kicked off a swathe of new studies. If so we’re Novartis not satisfied that suitable evidence would be provided in an appropriate time
3) is the product a dud - one would think not the case here because other jurisdictions are signing on (like NZ)
3) does the draft status have an appeals process - was it included in error. Likelihood that an error is way too small - this is critical information they are producing
removal of reimbursement is major. The only good news is they have a huge amount of cash to burn and if the SP was to crash it may provide a good buying opportunity for the brave
- Forums
- NZX - By Stock
- PEB
- Ann: Pacific Edge Limited ("PEB") - Trading Halt of Securities
Ann: Pacific Edge Limited ("PEB") - Trading Halt of Securities, page-7
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PEB (NZSX) to my watchlist
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
Previous Video
Next Video
SPONSORED BY The Market Online